Ticker Details
Quanterix Corporation Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health.
IPO Date:	December 7, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$154.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.72 | 3.08%
Avg Daily Range (30 D):	$0.14 | 3.22%
Avg Daily Range (90 D):	$0.19 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.63M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	89
Avg Trade Size (Sh.) (90 D):	80

Institutional Trades
Total Institutional Trades:	1,299
Avg Institutional Trade:	$1.32M
Avg Institutional Trade (30 D):	$.82M
Avg Institutional Trade (90 D):	$1.14M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.26M
Avg Closing Trade (30 D):	$.72M
Avg Closing Trade (90 D):	$1.13M
Avg Closing Volume:	47.91K

News

May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire

Apr 28, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc

Apr 2, 2025 @ 10:50 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc

Feb 18, 2025 @ 8:30 PM Quanterix Corporation Announcement: If You Have Su... Source: N/A

Feb 14, 2025 @ 11:30 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.51	$-.47	$-2.51
Diluted EPS	$-2.51	$-.47	$-2.51
Revenue	$138.9M	$43.86M	$138.9M
Gross Profit	$64.96M	$20.04M	$64.96M
Net Income / Loss	$-107.15M	$-23.12M	$-107.15M
Operating Income / Loss	$-125.54M	$-24.75M	$-125.54M
Cost of Revenue	$73.94M	$23.82M	$73.94M
Net Cash Flow	$-26.14M	$-8.45M	$-26.14M
PE Ratio